<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="letter" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">J. Cutan. Immunol. Allergy</journal-id>
<journal-title-group>
<journal-title>Journal of Cutaneous Immunology and Allergy</journal-title>
<abbrev-journal-title abbrev-type="pubmed">J. Cutan. Immunol. Allergy</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">2574-4593</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">17140</article-id>
<article-id pub-id-type="doi">10.3389/jcia.2026.17140</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Letter to the Editor</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Dissecting cellulitis of the occipital scalp with hair retention within sinus tracts</article-title>
<alt-title alt-title-type="left-running-head">Yamamura et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/jcia.2026.17140">10.3389/jcia.2026.17140</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yamamura</surname>
<given-names>Yuto</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<uri xlink:href="https://loop.frontiersin.org/people/3477938"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fujii</surname>
<given-names>Kazuyasu</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/3523437"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nishimura</surname>
<given-names>Kazutoshi</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Usui</surname>
<given-names>Shunya</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Otsuka</surname>
<given-names>Atsushi</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Department of Dermatology, Kindai University Hospital</institution>, <city>Osaka</city>, <country country="JP">Japan</country>
</aff>
<author-notes>
<corresp id="c001">
<label>&#x2a;</label>Correspondence: Kazuyasu Fujii, <email xlink:href="mailto:kazuyasu.fujii@med.kindai.ac.jp">kazuyasu.fujii@med.kindai.ac.jp</email>
</corresp>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-07-29">
<day>29</day>
<month>07</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>9</volume>
<elocation-id>17140</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>06</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>14</day>
<month>06</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>21</day>
<month>07</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2026 Yamamura, Fujii, Nishimura, Usui and Otsuka.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Yamamura, Fujii, Nishimura, Usui and Otsuka</copyright-holder>
<license>
<ali:license_ref start_date="2026-07-29">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<kwd-group>
<kwd>dissecting cellulitis of the scalp</kwd>
<kwd>follicular occlusion</kwd>
<kwd>hair retention</kwd>
<kwd>sinus tract</kwd>
<kwd>tufted hair</kwd>
</kwd-group>
<funding-group>
<funding-statement>The author(s) declared that financial support was not received for this work and/or its publication.</funding-statement>
</funding-group>
<counts>
<fig-count count="1"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="5"/>
<page-count count="3"/>
</counts>
</article-meta>
</front>
<body>
<p>Dear Editor,</p>
<p>Hidradenitis suppurativa (HS) is a chronic inflammatory disease based on follicular occlusion, characterized by recurrent nodules, abscesses, sinus tract formation, and scarring [<xref ref-type="bibr" rid="B1">1</xref>]. HS-like lesions occurring on the scalp are commonly referred to as dissecting cellulitis of the scalp (DCS), which also belongs to the group of follicular occlusion disorders [<xref ref-type="bibr" rid="B2">2</xref>]. Although biologic agents are effective for HS [<xref ref-type="bibr" rid="B3">3</xref>], their efficacy in DCS has not been well established.</p>
<p>Here, we report a case of DCS that was refractory to biologic therapy. This case showed characteristic structural changes, including the accumulation of hair shafts within sinus tracts, and we discuss their possible association with treatment resistance.</p>
<p>A man in his 40s presented with an 8-year history of nodular lesions on the occipital scalp, which gradually enlarged and were associated with pain, purulent discharge, and progressive hair loss. He had been diagnosed with HS at a previous clinic and treated with adalimumab for 1&#xa0;year, followed by bimekizumab for 6&#xa0;months; however, no clinical improvement was observed, and he was referred to our department.</p>
<p>At the initial visit, extensive scarring alopecia with tufted hair was observed on the occipital scalp, accompanied by erythema, induration, and purulent discharge from sinus tracts (<xref ref-type="fig" rid="F1">Figure 1A</xref>). The lesion extended approximately 13 &#xd7; 13&#xa0;cm. Incision and drainage followed by deroofing resulted in limited improvement, and elongated hair shafts extending within the subcutaneous tissue were exposed from the wound (<xref ref-type="fig" rid="F1">Figure 1B</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Clinical, gross, and histopathological findings of dissecting cellulitis of the scalp <bold>(A)</bold> Clinical presentation at the initial visit, showing extensive scarring alopecia with tufted hair. <bold>(B)</bold> Two weeks after deroofing. Elongated hair shafts extending within the subcutaneous tissue are exposed from the wound. <bold>(C)</bold> Gross appearance of the excised specimen. Thickened fibrotic tissue with sinus tract formation is observed, and hair shafts are present within the sinus tracts. <bold>(D)</bold> Histopathological findings. Fibrosis and sinus tract formation extending from the dermis to the subcutaneous tissue are observed, indicating structural destruction associated with chronic inflammation (hematoxylin and eosin stain; scale bar &#x3d; 5&#xa0;mm).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="jcia-09-17140-g001.tif">
<alt-text content-type="machine-generated">Panel A shows the back of a scalp with patchy hair loss, scarring, and inflamed lesions. Panel B is a close-up of the scalp with visible pustules, scarring, and abnormal hair growth. Panel C depicts a cross-section of excised scalp tissue showing hair follicles and underlying subcutaneous tissue. Panel D presents a histological slide stained with hematoxylin and eosin, illustrating skin architecture with inflammatory infiltrates and scarring.</alt-text>
</graphic>
</fig>
<p>Subsequently, wide excision was performed. On cross-section of the excised specimen, markedly thickened fibrotic tissue and numerous hair shafts within the sinus tracts were observed (<xref ref-type="fig" rid="F1">Figure 1C</xref>). Histopathological examination revealed destruction of follicular structures, inflammatory cell infiltration, fibrosis, and fusion of adjacent follicles, consistent with scarring alopecia (<xref ref-type="fig" rid="F1">Figure 1D</xref>). The postoperative course was uneventful, with no recurrence.</p>
<p>Tufted hair is a morphological finding in which multiple hair shafts emerge from a single dilated follicular opening, and is considered to result from destruction of the upper follicular structures and subsequent fibrosis leading to follicular fusion [<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>]. In the present case, an additional notable finding was the accumulation of hair shafts within sinus tracts. This may reflect impaired extrusion of hair shafts due to follicular destruction and fibrosis, resulting in their retention within the subcutaneous tissue.</p>
<p>In this patient, biologic therapy did not result in clinical improvement. While biologic agents are effective in controlling inflammation, their efficacy may be limited in fibrosis-dominant lesions such as scarring and sinus tracts [<xref ref-type="bibr" rid="B3">3</xref>]. The presence of scarring alopecia, tufted hair, and intralesional hair accumulation suggests that the disease had already progressed to a fibrosis-dominant stage at the time of treatment initiation.</p>
<p>This case of DCS was characterized by extensive scarring alopecia and tufted hair, with the notable finding of hair retention within sinus tracts. When scarring alopecia and tufted hair are present, fibrosis-dominant disease with underlying structural abnormalities, including subcutaneous hair retention, may be suspected. In such cases, the response to biologic therapy may be limited, and early consideration of surgical excision is warranted.</p>
</body>
<back>
<sec sec-type="data-availability" id="s1">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec sec-type="ethics-statement" id="s2">
<title>Ethics statement</title>
<p>Ethical approval was not required because this manuscript reports a single case based on clinical findings obtained during routine medical care, without any additional intervention or prospective research procedures. The study was conducted in accordance with the local legislation and institutional requirements. Written informed consent was obtained from the patient for the publication of this case report and any potentially identifiable images or data included in the article.</p>
</sec>
<sec sec-type="author-contributions" id="s3">
<title>Author contributions</title>
<p>YY: Conceptualization, Data curation, Investigation, Visualization, Writing &#x2013; original draft. KF: Supervision, Writing &#x2013; review and editing. KN: Writing &#x2013; review and editing. SU: Writing &#x2013; review and editing. AO: Writing &#x2013; review and editing. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec sec-type="COI-statement" id="s5">
<title>Conflict of interest</title>
<p>The authors declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s6">
<title>Generative AI statement</title>
<p>The author(s) declared that generative AI was used in the creation of this manuscript. OpenAI&#x2019;s ChatGPT was used for language editing and assistance with improving the clarity and readability of the manuscript. The AI tool was not used to generate clinical data, analyze data, create images, or make scientific conclusions. The authors carefully reviewed and approved all AI-assisted text and take full responsibility for the content of the manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sabat</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Alavi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Wolk</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wortsman</surname>
<given-names>X</given-names>
</name>
<name>
<surname>McGrath</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Garg</surname>
<given-names>A</given-names>
</name>
<etal/>
</person-group> <article-title>Hidradenitis suppurativa</article-title>. <source>Lancet</source> (<year>2025</year>) <volume>405</volume>(<issue>10476</issue>):<fpage>420</fpage>&#x2013;<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(24)02475-9</pub-id>
<pub-id pub-id-type="pmid">39862870</pub-id>
</mixed-citation>
</ref>
<ref id="B2">
<label>2.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Masson</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Crew</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Fragoso</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>VY</given-names>
</name>
<etal/>
</person-group> <article-title>Treatments for dissecting cellulitis of the scalp: a systematic review and treatment algorithm</article-title>. <source>Dermatol Ther (Heidelb)</source> (<year>2023</year>) <volume>13</volume>(<issue>11</issue>):<fpage>2487</fpage>&#x2013;<lpage>526</lpage>. <pub-id pub-id-type="doi">10.1007/s13555-023-01018-7</pub-id>
<pub-id pub-id-type="pmid">37740150</pub-id>
</mixed-citation>
</ref>
<ref id="B3">
<label>3.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zouboulis</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Bechara</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Benhadou</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bettoli</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bukvi&#x107; Mokos</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Del Marmol</surname>
<given-names>V</given-names>
</name>
<etal/>
</person-group> <article-title>European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: treatment</article-title>. <source>J Eur Acad Dermatol Venereol</source> (<year>2025</year>) <volume>39</volume>(<issue>5</issue>):<fpage>899</fpage>&#x2013;<lpage>941</lpage>. <pub-id pub-id-type="doi">10.1111/jdv.20472</pub-id>
<pub-id pub-id-type="pmid">39699926</pub-id>
</mixed-citation>
</ref>
<ref id="B4">
<label>4.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petroni&#x107;-Rosi&#x107;</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Kruni&#x107;</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mijuskovi&#x107;</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vesi&#x107;</surname>
<given-names>S</given-names>
</name>
</person-group>. <article-title>Tufted hair folliculitis: a pattern of scarring alopecia?</article-title> <source>J Am Acad Dermatol</source> (<year>1999</year>) <volume>41</volume>(<issue>1</issue>):<fpage>112</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/s0190-9622(99)70417-2</pub-id>
<pub-id pub-id-type="pmid">10411422</pub-id>
</mixed-citation>
</ref>
<ref id="B5">
<label>5.</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uchiyama</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Harada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Tobita</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Irisawa</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tsuboi</surname>
<given-names>R</given-names>
</name>
</person-group>. <article-title>Histopathologic and dermoscopic features of 42 cases of folliculitis decalvans: a case series</article-title>. <source>J Am Acad Dermatol</source> (<year>2021</year>) <volume>85</volume>(<issue>5</issue>):<fpage>1185</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2020.03.092</pub-id>
<pub-id pub-id-type="pmid">32272176</pub-id>
</mixed-citation>
</ref>
</ref-list>
</back>
</article>